Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies

F. Wang, S. Wang, Q. Q. Zong, Q. Zhang, C. H. Ng, G. S. Ungvari, Y. T. Xiang

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Aims: To examine the average point prevalence of major depressive disorder in people with Type 2 diabetes and its associated factors in a comprehensive meta-analysis. Methods: Two researchers independently conducted a systematic literature search of PubMed, EMBASE, PsycINFO and Cochrane databases. Studies reporting the prevalence of major depressive disorder in people with Type 2 diabetes were identified and analysed using a random-effects model. Results: A total of 26 studies meeting the inclusion criteria were included in the study. The point prevalence of major depressive disorder was 14.5% (95% CI 7.9–25.3; I²=99.65). People with Type 2 diabetes were more likely to have major depressive disorder compared with the general population (odds ratio 1.73, 95% CI 1.38–2.16). Subgroup and meta-regression analyses showed that study site, study type, diagnostic criteria and age significantly moderated the prevalence of major depressive disorder. Conclusions: In this meta-analysis, the average point prevalence of major depressive disorder in people with Type 2 diabetes was high. Routine screening and more effective interventions should be implemented for this population.

Original languageEnglish
Pages (from-to)961-969
Number of pages9
JournalDiabetic Medicine
Volume36
Issue number8
DOIs
Publication statusPublished - 1 Aug 2019

Fingerprint

Major Depressive Disorder
Type 2 Diabetes Mellitus
Meta-Analysis
Epidemiologic Studies
PubMed
Population
Cross-Sectional Studies
Odds Ratio
Regression Analysis
Research Personnel
Databases

Cite this

Wang, F. ; Wang, S. ; Zong, Q. Q. ; Zhang, Q. ; Ng, C. H. ; Ungvari, G. S. ; Xiang, Y. T. / Prevalence of comorbid major depressive disorder in Type 2 diabetes : a meta-analysis of comparative and epidemiological studies. In: Diabetic Medicine. 2019 ; Vol. 36, No. 8. pp. 961-969.
@article{938647dccd5f4199b3036f8a60b24e74,
title = "Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies",
abstract = "Aims: To examine the average point prevalence of major depressive disorder in people with Type 2 diabetes and its associated factors in a comprehensive meta-analysis. Methods: Two researchers independently conducted a systematic literature search of PubMed, EMBASE, PsycINFO and Cochrane databases. Studies reporting the prevalence of major depressive disorder in people with Type 2 diabetes were identified and analysed using a random-effects model. Results: A total of 26 studies meeting the inclusion criteria were included in the study. The point prevalence of major depressive disorder was 14.5{\%} (95{\%} CI 7.9–25.3; I²=99.65). People with Type 2 diabetes were more likely to have major depressive disorder compared with the general population (odds ratio 1.73, 95{\%} CI 1.38–2.16). Subgroup and meta-regression analyses showed that study site, study type, diagnostic criteria and age significantly moderated the prevalence of major depressive disorder. Conclusions: In this meta-analysis, the average point prevalence of major depressive disorder in people with Type 2 diabetes was high. Routine screening and more effective interventions should be implemented for this population.",
author = "F. Wang and S. Wang and Zong, {Q. Q.} and Q. Zhang and Ng, {C. H.} and Ungvari, {G. S.} and Xiang, {Y. T.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1111/dme.14042",
language = "English",
volume = "36",
pages = "961--969",
journal = "Diabetic Medicine: journal of diabetes UK",
issn = "0742-3071",
publisher = "John Wiley & Sons",
number = "8",

}

Prevalence of comorbid major depressive disorder in Type 2 diabetes : a meta-analysis of comparative and epidemiological studies. / Wang, F.; Wang, S.; Zong, Q. Q.; Zhang, Q.; Ng, C. H.; Ungvari, G. S.; Xiang, Y. T.

In: Diabetic Medicine, Vol. 36, No. 8, 01.08.2019, p. 961-969.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Prevalence of comorbid major depressive disorder in Type 2 diabetes

T2 - a meta-analysis of comparative and epidemiological studies

AU - Wang, F.

AU - Wang, S.

AU - Zong, Q. Q.

AU - Zhang, Q.

AU - Ng, C. H.

AU - Ungvari, G. S.

AU - Xiang, Y. T.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Aims: To examine the average point prevalence of major depressive disorder in people with Type 2 diabetes and its associated factors in a comprehensive meta-analysis. Methods: Two researchers independently conducted a systematic literature search of PubMed, EMBASE, PsycINFO and Cochrane databases. Studies reporting the prevalence of major depressive disorder in people with Type 2 diabetes were identified and analysed using a random-effects model. Results: A total of 26 studies meeting the inclusion criteria were included in the study. The point prevalence of major depressive disorder was 14.5% (95% CI 7.9–25.3; I²=99.65). People with Type 2 diabetes were more likely to have major depressive disorder compared with the general population (odds ratio 1.73, 95% CI 1.38–2.16). Subgroup and meta-regression analyses showed that study site, study type, diagnostic criteria and age significantly moderated the prevalence of major depressive disorder. Conclusions: In this meta-analysis, the average point prevalence of major depressive disorder in people with Type 2 diabetes was high. Routine screening and more effective interventions should be implemented for this population.

AB - Aims: To examine the average point prevalence of major depressive disorder in people with Type 2 diabetes and its associated factors in a comprehensive meta-analysis. Methods: Two researchers independently conducted a systematic literature search of PubMed, EMBASE, PsycINFO and Cochrane databases. Studies reporting the prevalence of major depressive disorder in people with Type 2 diabetes were identified and analysed using a random-effects model. Results: A total of 26 studies meeting the inclusion criteria were included in the study. The point prevalence of major depressive disorder was 14.5% (95% CI 7.9–25.3; I²=99.65). People with Type 2 diabetes were more likely to have major depressive disorder compared with the general population (odds ratio 1.73, 95% CI 1.38–2.16). Subgroup and meta-regression analyses showed that study site, study type, diagnostic criteria and age significantly moderated the prevalence of major depressive disorder. Conclusions: In this meta-analysis, the average point prevalence of major depressive disorder in people with Type 2 diabetes was high. Routine screening and more effective interventions should be implemented for this population.

UR - http://www.scopus.com/inward/record.url?scp=85068357486&partnerID=8YFLogxK

U2 - 10.1111/dme.14042

DO - 10.1111/dme.14042

M3 - Review article

VL - 36

SP - 961

EP - 969

JO - Diabetic Medicine: journal of diabetes UK

JF - Diabetic Medicine: journal of diabetes UK

SN - 0742-3071

IS - 8

ER -